成人T细胞白血病-淋巴瘤的造血干细胞移植：谁是最佳候选者？ - Suppr

Suppr

超能文献

Hematopoeitic stem cell transplantation for adult T cell leukemia-lymphoma: Who is the best candidate?

作者信息

Phillips Adrienne Alise

机构信息

a Division of Hematology and Oncology, Department of Medicine , Weill Cornell Medical College , New York , NY , USA.

出版信息

Leuk Lymphoma. 2017 Jan;58(1):1-3. doi: 10.1080/10428194.2016.1246730. Epub 2016 Oct 27.

DOI:10.1080/10428194.2016.1246730

PMID:27786571

Abstract

摘要

相似文献

Hematopoeitic stem cell transplantation for adult T cell leukemia-lymphoma: Who is the best candidate?成人T细胞白血病-淋巴瘤的造血干细胞移植：谁是最佳候选者？

Leuk Lymphoma. 2017 Jan;58(1):1-3. doi: 10.1080/10428194.2016.1246730. Epub 2016 Oct 27.

HLA-haploidentical hematopoietic stem cell transplantation with low-dose thymoglobulin GVHD prophylaxis for an adult T cell leukemia/lymphoma patient treated with pretransplant mogamulizumab.低剂量抗胸腺细胞球蛋白预防移植物抗宿主病的HLA单倍型相合造血干细胞移植，用于一名移植前接受莫加莫拉单抗治疗的成人T细胞白血病/淋巴瘤患者

Ann Hematol. 2017 Feb;96(2):327-328. doi: 10.1007/s00277-016-2856-y. Epub 2016 Oct 21.

Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.upfront异基因造血干细胞移植在侵袭性成人T细胞白血病-淋巴瘤患者中的作用：一项决策分析

Bone Marrow Transplant. 2018 Jul;53(7):905-908. doi: 10.1038/s41409-017-0082-4. Epub 2018 Jan 25.

High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia.移植时血清可溶性白细胞介素-2受体水平高预示成人T细胞白血病异基因干细胞移植预后不良。

Biol Blood Marrow Transplant. 2014 Jun;20(6):801-5. doi: 10.1016/j.bbmt.2014.02.014. Epub 2014 Feb 22.

Newly identified poor prognostic factors for adult T-cell leukemia-lymphoma treated with allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植治疗成人T细胞白血病-淋巴瘤新发现的不良预后因素。

Leuk Lymphoma. 2017 Jan;58(1):37-44. doi: 10.1080/10428194.2016.1187270. Epub 2016 Sep 22.

[Adult T-cell leukemia: application of allogeneic hematopoietic stem cell transplantation].[成人T细胞白血病：异基因造血干细胞移植的应用]

Rinsho Ketsueki. 2003 May;44(5):265-71.

Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation.70岁及以下侵袭性成人T细胞白血病-淋巴瘤患者改良预后指数的制定：包括异基因移植在内的可能的风险适应性管理策略。

Haematologica. 2017 Jul;102(7):1258-1265. doi: 10.3324/haematol.2017.164996. Epub 2017 Mar 24.

Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma.成人T细胞白血病/淋巴瘤的异基因干细胞移植

Int J Hematol. 2007 Aug;86(2):118-25. doi: 10.1532/IJH97.07070.

Frosted branch angiitis after allogeneic haematopoietic stem cell transplantation in adult T-cell leukaemia-lymphoma.成人T细胞白血病-淋巴瘤异基因造血干细胞移植后的霜枝样血管炎

Lancet Haematol. 2020 Oct;7(10):e772. doi: 10.1016/S2352-3026(20)30226-X.

Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation.复发侵袭性成人T细胞白血病-淋巴瘤患者的预后：抗CCR4抗体及异基因造血干细胞移植的临床疗效

Haematologica. 2018 May;103(5):e211-e214. doi: 10.3324/haematol.2017.184564. Epub 2018 Jan 25.

引用本文的文献

Clinical Characteristics and Outcomes of Caribbean Patients With Adult T-Cell Lymphoma/Leukemia at Two Affiliated New York City Hospitals.加勒比海地区成人 T 细胞淋巴瘤/白血病患者在纽约市两家附属医院的临床特征和结局。

JCO Glob Oncol. 2020 Apr;6:548-556. doi: 10.1200/JGO.19.00208.

Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center.美国人类 T 细胞嗜淋巴细胞病毒 1 相关成人 T 细胞淋巴瘤白血病异体造血干细胞移植的障碍：来自主要三级中心大型队列的经验。

Biol Blood Marrow Transplant. 2019 Jun;25(6):e199-e203. doi: 10.1016/j.bbmt.2019.02.004. Epub 2019 Feb 12.

Adult T Cell Leukemia-Lymphoma (ATL): State of the Art.成人 T 细胞白血病-淋巴瘤（ATL）：最新进展。

Curr Hematol Malig Rep. 2018 Aug;13(4):300-307. doi: 10.1007/s11899-018-0458-6.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验